SIOP PODC–adapted treatment guidelines for craniopharyngioma in low‐ and middle‐income settings
暂无分享,去创建一个
A. Figaji | S. Bailey | U. Bartels | E. Bouffet | N. Esiashvili | M. Sullivan | S. Cavalheiro | N. Mushtaq | M. Zaghloul | Patricia Alcasabas | J. Parkes | H. Muller | P. Dastoli | A. Davidson | F. Mubarak | Y. Yousef | A. Musharbash | M. Elhassan | N. Amayiri | A. Spitaels | M. Beltagy | Omar Chamdine | M. D. D. da Costa
[1] S. Rivkees. Thyroid Disorders in Children and Adolescents , 2021, Sperling Pediatric Endocrinology.
[2] A Jackson,et al. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[3] H. Müller. Childhood-onset craniopharyngioma: state of the art of care in 2018 , 2019 .
[4] H. Müller,et al. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up , 2018, Expert review of neurotherapeutics.
[5] C. Thiel,et al. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma , 2018, Journal of Neuro-Oncology.
[6] C. Roth,et al. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection , 2018, The Journal of clinical endocrinology and metabolism.
[7] R. Mekary,et al. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis. , 2018, World neurosurgery.
[8] Grace Nelson,et al. Delayed Puberty. , 2018, Pediatric annals.
[9] G. Johannsson,et al. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. , 2018, European journal of endocrinology.
[10] I. Yilmaz,et al. Comparison of visual acuity measurements via three different methods in preschool children: Lea symbols, crowded Lea symbols, Snellen E chart , 2018, International Ophthalmology.
[11] M. Warmuth-Metz,et al. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007 , 2018, Endocrine.
[12] D. Johnston,et al. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN , 2017, Neuro-oncology.
[13] C. Catsman-Berrevoets,et al. Very long-term sequelae of craniopharyngioma. , 2017, European journal of endocrinology.
[14] P. Beck‐Peccoz,et al. Central hypothyroidism — a neglected thyroid disorder , 2017, Nature Reviews Endocrinology.
[15] Ari J. Wassner. Pediatric Hypothyroidism: Diagnosis and Treatment , 2017, Pediatric Drugs.
[16] T. Merchant,et al. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma , 2017, Nature Reviews Endocrinology.
[17] J. Drake,et al. Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience , 2017, Child's Nervous System.
[18] C. Thiel,et al. First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma , 2017, Endocrine.
[19] P. Murray,et al. Diagnosis of growth hormone deficiency in the paediatric and transitional age. , 2016, Best practice & research. Clinical endocrinology & metabolism.
[20] A. Olch,et al. A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. , 2016, Neurosurgical focus.
[21] Patrick C Hanley,et al. Thyroid Disorders in Children and Adolescents: A Review. , 2016, JAMA pediatrics.
[22] C. Thiel,et al. Oxytocin in survivors of childhood-onset craniopharyngioma , 2016, Endocrine.
[23] Jennifer L Miller,et al. Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma , 2016, Journal of pediatric endocrinology & metabolism : JPEM.
[24] Timothy R. Smith,et al. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study. , 2016, Journal of neurosurgery. Pediatrics.
[25] M. Warmuth-Metz,et al. Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma , 2016, The Journal of clinical endocrinology and metabolism.
[26] M. Didi,et al. The diagnosis and treatment of adrenal insufficiency during childhood and adolescence , 2016, Archives of Disease in Childhood.
[27] Elizabeth Dabrowski,et al. Diabetes insipidus in infants and children. , 2016, Best practice & research. Clinical endocrinology & metabolism.
[28] H. Müller. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity , 2015, Current opinion in endocrinology, diabetes, and obesity.
[29] K. Makino,et al. Quality of Life and Clinical Features of Long-Term Survivors Surgically Treated for Pediatric Craniopharyngioma. , 2016, World neurosurgery.
[30] H. Müller. Craniopharyngioma: long-term consequences of a chronic disease , 2015, Expert review of neurotherapeutics.
[31] C. Thiel,et al. A systematic review of cognitive performance in patients with childhood craniopharyngioma , 2015, Journal of Neuro-Oncology.
[32] H. Müller,et al. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. , 2015, European journal of endocrinology.
[33] H. Müller,et al. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma , 2015, Journal of pediatric endocrinology & metabolism : JPEM.
[34] M. Dattani,et al. Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence , 2015, Archives of Disease in Childhood.
[35] M. Warmuth-Metz,et al. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. , 2015, Neuro-oncology.
[36] M. Warmuth-Metz,et al. Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis. , 2015, European journal of endocrinology.
[37] A. Albanese,et al. Management of Electrolyte and Fluid Disorders after Brain Surgery for Pituitary/Suprasellar Tumours , 2015, Hormone Research in Paediatrics.
[38] Cinzia Talamonti,et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] S. Bailey,et al. Intracystic interferon therapy in childhood craniopharyngioma: who, when and how? , 2015, Clinical endocrinology.
[40] R. Quinton,et al. Transition in endocrinology: induction of puberty. , 2014, European journal of endocrinology.
[41] G. Zada,et al. Prevalence of Neurobehavioral, Social, and Emotional Dysfunction in Patients Treated for Childhood Craniopharyngioma: A Systematic Literature Review , 2013, PloS one.
[42] L. Rylander,et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. , 2013, The Journal of clinical endocrinology and metabolism.
[43] M. Mahmoud,et al. Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study , 2013, British journal of neurosurgery.
[44] M. Polak,et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. , 2013, The Journal of clinical endocrinology and metabolism.
[45] T. Merchant,et al. Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. , 2013, International journal of radiation oncology, biology, physics.
[46] H. Müller. Childhood craniopharyngioma , 2020, Pituitary.
[47] K. Auguste,et al. A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma , 2013, Child's Nervous System.
[48] S. Puget. Treatment Strategies in Childhood Craniopharyngioma , 2012, Front. Endocrin..
[49] J. Blair,et al. Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system , 2012, Child's Nervous System.
[50] K. Wang,et al. Vasculopathy after intracystic bleomycin administration for a recurrent cystic craniopharyngioma: case report. , 2012, Journal of neurosurgery. Pediatrics.
[51] J. Drake,et al. Intracystic Therapies for Cystic Craniopharyngioma in Childhood , 2011, Front. Endocrin..
[52] C. Roth,et al. Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity , 2011, Front. Endocrin..
[53] R. Kortmann. Different Approaches in Radiation Therapy of Craniopharyngioma , 2011, Front. Endocrin..
[54] T. Pietsch,et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. , 2011, European journal of endocrinology.
[55] Jennifer L. Hammond,et al. Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma , 2011, Developmental medicine and child neurology.
[56] Christina Bougatsos,et al. Screening for Visual Impairment in Children Ages 1–5 Years: Update for the USPSTF , 2011, Pediatrics.
[57] S. Cavalheiro,et al. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. , 2010, Neurosurgical focus.
[58] Charles Mayo,et al. Radiation associated brainstem injury. , 2010, International journal of radiation oncology, biology, physics.
[59] Adam P Dicker,et al. Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.
[60] Joseph O Deasy,et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.
[61] Charles Mayo,et al. Radiation dose-volume effects of optic nerves and chiasm. , 2009, International journal of radiation oncology, biology, physics.
[62] T. Pietsch,et al. Analyses of Treatment Variables for Patients with Childhood Craniopharyngioma – Results of the Multicenter Prospective Trial KRANIOPHARYNGEOM 2000 after Three Years of Follow-Up , 2008, Hormone Research in Paediatrics.
[63] S. Cavalheiro,et al. Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment? , 2008, Surgical neurology.
[64] C. Stratakis,et al. Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics , 2008, Expert review of neurotherapeutics.
[65] I. El Naqa,et al. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. , 2008, Journal of neurosurgery. Pediatrics.
[66] S. Puget,et al. Craniopharyngioma , 2007, Orphanet journal of rare diseases.
[67] S. Puget,et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. , 2007, Journal of neurosurgery.
[68] M. Flentje,et al. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. , 2006, Klinische Padiatrie.
[69] H. Müller,et al. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma , 2006 .
[70] F. Saran,et al. A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[71] M. Hafez,et al. Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[72] R. Mulhern,et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. , 2006, Journal of neurosurgery.
[73] H. Müller,et al. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[74] N. Boddaert,et al. Craniopharyngioma: the pendulum of surgical management , 2005, Child's Nervous System.
[75] S. Chokron,et al. Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood , 2005, Child's Nervous System.
[76] T. Yurtseven,et al. Craniopharyngiomas in children: Turkey experience , 2005, Child's Nervous System.
[77] K. Wang,et al. Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas—a study in single institute , 2005, Child's Nervous System.
[78] C. Sarkar,et al. Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features , 2005, Child's Nervous System.
[79] L. Solymosi,et al. Differential diagnosis of suprasellar tumors in children. , 2004, Klinische Padiatrie.
[80] A. Poretti,et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. , 2004, Developmental medicine and child neurology.
[81] B. Larijani,et al. Presentation and outcome of 93 cases of craniopharyngioma. , 2004, European journal of cancer care.
[82] V. Nottidge,et al. Craniopharyngioma in Nigerian children , 1988, Child's Nervous System.
[83] Christoph Kniestedt,et al. Visual acuity and its measurement. , 2003, Ophthalmology clinics of North America.
[84] Matthew W. Wilson,et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. , 2002, International journal of radiation oncology, biology, physics.
[85] Zhen-yu Ma,et al. Pediatric Craniopharyngiomas: Clinicomorphological Study of 189 Cases , 2002, Pediatric Neurosurgery.
[86] Growth Hormone Research Society,,et al. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society , 2001 .
[87] M. M. Ilondo,et al. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society , 2000 .
[88] Y. Kanpolat,et al. Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. , 2000, Neurosurgery.
[89] J. Habrand,et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. , 1999, International journal of radiation oncology, biology, physics.
[90] D. Riva,et al. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma , 1998, Child's Nervous System.
[91] K. Watkins,et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? , 1996, Journal of neurosurgery.
[92] S. Jani,et al. A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. , 1987, International journal of radiation oncology, biology, physics.
[93] L. Ghizzoni,et al. Delayed puberty. , 2002, Best practice & research. Clinical endocrinology & metabolism.